VON WILLEBRAND DISEASE
Clinical trials for VON WILLEBRAND DISEASE explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare bleeding disorder: study tests rVWF treatment
Disease control CompletedThis study tested a medicine called vonicog alfa (rVWF) to control bleeding in 47 children under 18 with severe von Willebrand disease, a genetic bleeding disorder. The treatment was given with or without another factor product (ADVATE) for 12-18 months. The goal was to see how w…
Matched conditions: VON WILLEBRAND DISEASE
Phase: PHASE3 • Sponsor: Baxalta now part of Shire • Aim: Disease control
Last updated May 17, 2026 12:29 UTC
-
New hope for toddlers with rare bleeding disorder: wilate shows promise in preventing bleeds
Disease control CompletedThis study tested a medicine called wilate in 12 children under 6 years old with severe von Willebrand disease, a bleeding disorder. The goal was to see if regular infusions of wilate could prevent bleeding episodes over a year. The study measured how many bleeds occurred, how th…
Matched conditions: VON WILLEBRAND DISEASE
Phase: PHASE3 • Sponsor: Octapharma • Aim: Disease control
Last updated May 17, 2026 12:28 UTC